NCT04831606View on ClinicalTrials.gov

Blue Light Photobiomodulation Therapy on Neuroischemic Patients

NATerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Diabetic Foot Ulcer
Interventions
PROCEDURE

debridement

Cleaning of the wound area

DEVICE

Offloading

Offloading performed with a standard brace to the calf (Optima Diab, from Molliter).

DEVICE

Advanced dressing

Protect the wound with Advanced dressing

DEVICE

Blue Light Photobiomodulation

2 minutes irradiation of blue light performed with EmoLED device

Trial Locations (1)

52100

San Donato Hospital, Arezzo

Sponsors

Lead Sponsor

Emoled
All Listed Sponsors
collaborator

Ospedale San Donato

OTHER

collaborator

University of Pisa

OTHER

lead

Emoled

INDUSTRY

NCT04831606 - Blue Light Photobiomodulation Therapy on Neuroischemic Patients | Biotech Hunter | Biotech Hunter